Corina Madreiter-Sokolowski

CMS-LAB

Cells & C. elegans –
Mitochondria –
Signaling

Mitochondrial (Dys)FunCtion
in Aging and diseases

We explore how mitochondria function – and sometimes fail – during aging, in age-related diseases, and in Dravet syndrome. 

Using cutting-edge fluorescence microscopy, we study signal pathways in a range of experimental systems, from cellular aging models and cancer cells to patient-derived cells and nematodes (Caenorhabditis elegans). 

Our ultimate goal is to turn these insights into new strategies to keep cells healthier for longer and to improve treatments for age-related diseases, cancer, and Dravet syndrome.

Corina Madreiter-Sokolowski
Associate Professor

As an Associate Professor at the
Molecular Biology and Biochemistry at the Medical University of Graz
, Corina Madreiter-Sokolowski focuses on understanding mitochondrial function in aging and diseases.

With a background in pharmacy and extensive international experience at renowned institutions like ETH Zurich, Corina Madreiter-Sokolowski leads a research group dedicated to developing innovative strategies to improve health across the lifespan.

Award-winning science

Corina Madreiter-Sokolowski’s research in mitochondrial function in aging and diseases has been honored with numerous prestigious awards. Highlights include the 2017 Award of Excellence from the Federal Ministry of Education, Science and Research, the 2022 Elisabeth Lutz Prize from the Austrian Academy of Sciences (ÖAW), and the 2021 GRAWE Award from Graz Mutual Insurance Company.

She has also received the 2018 Erwin Schrödinger Abroad Fellowship from the Austrian Science Fund (FWF), the 2022 Scientific Exchange Grant from EMBO, and the 2023 Josef Krainer Award. These accolades reflect her dedication to advancing scientific knowledge and excellence.

Award of Excellence

Federal Ministry of Education, Science and Research

Elisabetz Lutz Prize

Austrian Academy of Sciences (ÖAW)

Grawe Award

Graz Mutual Insurance Company

2023      Josef Krainer Würdigungspreis

2022      Scientific Exchange Grant – European Molecular Biology Organization (EMBO)

2022      Preidler/Szolar Fellowship – MEFOgraz

2022      Elisabeth Lutz Prize – Austrian Academy of Sciences (ÖAW)

2021      GRAWE Award 2021 – Graz Mutual Insurance Company (GRAWE)

2018      Erwin Schrödinger Abroad Fellowship (stay-abroad at the ETH Zurich) – Austrian Science Fund (FWF)

2017      Sanofi Research Prize – Sanofi

2017      Comprehensive Cancer Center (CCC) Thesis Award

2014      Poster Prize Cardiovascular Research Doc Day

Our Research

Promotion of lifespan by mitochondrial Calcium and ROS homeostasis

Reactive oxygen species (ROS) play a dual role in cellular biology: they are essential for signal transduction but can cause significant damage when present in excess. In this project, we use nematodes (Caenorhabditis elegans) and cellular aging models to explore how mitochondrial calcium regulation influences ROS levels. Our goal is to uncover mechanisms that modulate ROS in a targeted way, promoting lifespan extension and improved fitness in old age. For more information about our project, please visit the FWF Research Radar.

Interorganellar communication in cellular senescence

The FWF research group SENIOPROM is dedicated to uncovering the mechanisms driving cellular senescence. Our focus includes mitochondrial function, interactions between mitochondria and other organelles, metabolic regulation, and the maintenance of functional proteins. By understanding these processes, we aim to lay the foundation for new therapeutic strategies to selectively eliminate senescent cells, ultimately contributing to healthier aging and improved quality of life. For more information about our project, please visit the FWF Research Radar.

T3-induced rewiring of mitochondrial calcium in cancer cells

Thyroid hormones are master regulators of cellular metabolism and play a critical role in cancer cells, which depend on energy to support their invasive growth. We study how thyroid hormones influence mitochondrial calcium homeostasis, thereby impacting mitochondrial function and energy production in various cancer cell types. For more information about our project, please visit the FWF Research Radar.

Mitochondrial (dys)function in Dravet syndrome

Dravet syndrome is a severe, early-onset epileptic encephalopathy. We focus on understanding how impaired mitochondrial function affects energy metabolism, cellular signaling, and overall cellular health. By unraveling these mechanisms, we aim to identify potential therapeutic targets that could mitigate mitochondrial dysfunction and improve outcomes for individuals with Dravet syndrome. For more information about our project, please visit the FWF Research Radar.

Our Publications

Explore our recent research dedicated to mitochondrial function in aging and diseases. Our work, published in leading scientific journals, showcases discoveries and innovative approaches. Stay updated with our latest findings and contributions to the scientific community through our comprehensive publication list on PubMed.

Bresilla D, Tawfik I, Hirtl M, Gabrijelčič S, Ostaku J, Mossegger F, Wurzer L, Lederer S, Kalinova K, Malle E, Schosserer M, Zarse K, Ristow M, Madreiter-Sokolowski CT. Enhancing late-life survival and mobility via mitohormesis by reducing mitochondrial calcium levels. Aging Cell. 2025. DOI: 10.1111/acel.70247

Reducing mitochondrial calcium uptake in C. elegans – either by knocking down the uniporter gene mcu-1 or by the drug mitoxantrone – triggers a transient ROS signal that activates stress-response pathways (pmk-1/p38, daf-16/FOXO, skn-1/NRF2), preserves mitochondrial structure and function, and thereby extends lifespan and late-life mobility.

We showed that endometriotic 12Z cells share cancer cell-like mitochondrial structural changes and vulnerabilities, with a unique reliance on reverse FOF1-ATP synthase activity and electron transport chain function, suggesting these as potential therapeutic targets for endometriosis.

We discovered that breast cancer cells harness T3 to upregulate IP3R3 through THRα, enhancing mitochondrial Ca²⁺ uptake and driving cancer cell metabolism and proliferation.

We revealed that age-related metabolic alterations emerge as early as 6 months in mice, often exhibiting a biphasic pattern.

We discovered that cancer cells leverage T3 to rewire mitochondrial calcium homeostasis by specifically upregulating UCP2.

We demonstrated that green tea catechins induce a mitohormetic response by inhibiting complex I of the electron transport chain, thereby promoting health and extending lifespan in C. elegans.

We found that cancer cells dynamically modulate the interaction between mitochondria and the endoplasmic reticulum, which inversely correlates with the expression of mitochondrial calcium uptake proteins.

We revealed that MICU1, the mitochondrial calcium gatekeeper, anchors MCU and EMRE at the inner boundary membrane in response to elevated calcium levels.

We discovered that senescent cells exhibit an enhanced physical interaction between mitochondria and the endoplasmic reticulum, rendering them particularly susceptible to mitochondrial calcium-overload provoking agents such as resveratrol.

We demonstrated that cancer cells with concurrent upregulation of UCP2 and PRMT1 exhibit enhanced metabolism, a condition associated with reduced survival probability in lung cancer patients with co-expression of these genes.

We discovered that PRMT1-mediated methylation of MICU1 impairs mitochondrial calcium uptake, a dysfunction counteracted by UCP2 in cancer cells.

We found that resveratrol-induced ATP synthase inhibition reduces cellular ATP levels, impairing SERCA activity and leading to mitochondrial calcium overload.

Interested in our work?
Contact us!
Learn more about our team!
Explore our science communication!